Titlebook: Drugs, Driving and Traffic Safety; Joris C. Verster,S. R. Pandi-Perumal,Johan J. Gier Book 2009 Birkh?user Basel 2009 ICADTS.Parkinson.att

Ptsd429

Pharmacokinetics and pharmacodynamics of drugs abused in driving,okinetic studies to help officials identify drugged drivers and remove them from the roadways. Current approaches for drugs of abuse other than alcohol first determine an estimate of time of use from concentrations of drugs and metabolites in bodily fluids following controlled drug administration. T

Omniscient

東西

Sleepiness, countermeasures and the risk of motor vehicle accidents,to travel at high speeds and for long distances in a comfortable and often sleep promoting driving environment. Recent decades have seen an increase in shift work and apparent trends for reduced sleep length, which combine to increase driving risk, particularly with night driving. The young appear m

尖牙

Insomnia, hypnotic drugs and traffic safety,cts that may affect daily activities such as driving a car. Epidemiological studies show that patients who use sleep medication are at increased risk of becoming involved in traffic accidents. These studies show an increased traffic accident risk for patients using benzodiazepine hypnotics or zopicl

ADORN

諄諄教誨

Drugs, driving and traffic safety in shift workers,ness. Intolerance to shift work may lead to Shift Work Sleep Disorder (SWSD), primarily characterized by insomnia and excessive sleepiness..The effects of shift work on driving ability and traffic safety have been demonstrated in a number of epidemiological and driving simulator studies. The main co

男學(xué)院

Effects of anxiolytics on driving,e reviewed in the next chapter. This chapter reviews the results of ten experimental studies investigating the effects of anxiolytics on driving performance using over-the-road tests. Results show that only the serotonergic drugs (buspirone, ondansetron and ritanserin) had a low potential for impair

Spirometry

Antidepressants and traffic safety,s (SSRIs). Both groups of drugs have proven to be effective in treating depressive symptoms, however they differ in adverse effect profile. This chapter discusses their effects on driving ability. On the road driving tests have shown that TCAs such as imipramine, doxepine and amitriptilyne significa

平項(xiàng)山

Attention deficit/hyperactivity disorder (ADHD) and driving safety,ted to elevated risk of driving mishaps, a theoretical model concerning how these symptoms and their appropriate medical management impact on driving safety, and both the advantages and disadvantages of ADHD medication management.

Valves

Joris C. Verster,S. R. Pandi-Perumal,Johan J. GierProvides an overview of psychoactive drugs and medications.Covers a wide range of medical conditions and medication.Includes guidelines on studies of driving capability